Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Polycystic Kidney Disease”

Showing 20 of 0 results

Not applicableStudy completedNCT02250287
What this trial is testing

New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Autosomal Dominant Polycystic Kidney DiseaseKidney Disease
Mayo Clinic 20
Testing effectiveness (Phase 2)Study completedNCT03541447
What this trial is testing

Tolvaptan-Octreotide LAR Combination in ADPKD

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Mario Negri Institute for Pharmacological Research 20
Testing effectiveness (Phase 2)Looking for participantsNCT05478083
What this trial is testing

A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease

Who this might be right for
Polycystic Liver DiseaseAutosomal Dominant Polycystic Kidney
University Medical Center Groningen 36
Large-scale testing (Phase 3)Study completedNCT01022424
What this trial is testing

A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) (2) [Extension of Study 156-05-002]

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Otsuka Pharmaceutical Co., Ltd. 13
Early research (Phase 1)Study completedNCT04908462
What this trial is testing

To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AL01211 in Healthy Volunteers

Who this might be right for
Autosomal Dominant Polycystic Kidney
AceLink Therapeutics, Inc. 69
Early research (Phase 1)Not Yet RecruitingNCT07463053
What this trial is testing

Mass Balance and Absolute Bioavailability Study of JMKX003142 In Healthy Volunteers

Who this might be right for
ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Jemincare 8
Large-scale testing (Phase 3)Study completedNCT00428948
What this trial is testing

Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Who this might be right for
Polycystic Kidney Disease, Autosomal Dominant
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,445
Not applicableUnknownNCT02729662
What this trial is testing

Efficacy of Tolvaptan on ADPKD Patients

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Kyorin University 118
Early research (Phase 1)Not Yet RecruitingNCT07565441
What this trial is testing

Drug-Drug Interactions of JMKX003142 in Healthy Participants

Who this might be right for
ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Jemincare 112
Early research (Phase 1)Study completedNCT05521191
What this trial is testing

RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Autosomal Dominant Polycystic Kidney DiseaseADPKDPolycystic Kidney, Autosomal Dominant
Regulus Therapeutics Inc. 68
Large-scale testing (Phase 3)Ended earlyNCT04152837
What this trial is testing

Safety of Lixivaptan in Subjects Previously Treated With Tolvaptan for Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Polycystic Kidney Disease, AdultADPKD
Palladio Biosciences 7
Large-scale testing (Phase 3)Study completedNCT00309283
What this trial is testing

Somatostatin in Polycystic Kidney: a Long-term Three Year Follow up Study

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Mario Negri Institute for Pharmacological Research 78
Early research (Phase 1)Active Not RecruitingNCT06734234
What this trial is testing

Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Kidney Disease
GlaxoSmithKline 86
Testing effectiveness (Phase 2)UnknownNCT01932450
What this trial is testing

Radiofrequency Ablation for ADPKD Blood Pressure and Disease Progression Control

Who this might be right for
Autosomal Dominant Polycystic Kidney DiseaseHypertension
Mei changlin 100
Post-approval studies (Phase 4)Study completedNCT05228574
What this trial is testing

Treatment of Vascular Stiffness in ADPKD

Who this might be right for
Autosomal Dominant Polycystic Kidney
Erasmus Medical Center 46
Not applicableActive Not RecruitingNCT05288998
What this trial is testing

Intrarenal Microvasculature in ADPKD

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Mayo Clinic 34
Testing effectiveness (Phase 2)Looking for participantsNCT06582875
What this trial is testing

Glucagon-Like Peptide-1 Receptor Agonist in ADPKD

Who this might be right for
Autosomal Dominant Polycystic KidneyObesity
University of Colorado, Denver 126
Large-scale testing (Phase 3)Ended earlyNCT03523728
What this trial is testing

A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients

Who this might be right for
Polycystic Kidney, Autosomal Dominant
Genzyme, a Sanofi Company 478
Large-scale testing (Phase 3)Study completedNCT02119013
What this trial is testing

Effects of Somatostatin on ADPKD Heart

Who this might be right for
Autosomal Dominant Polycystic Kidney DiseaseGlomerular Filtration Rate > 40 ml/Min
Federico II University 35
Not applicableActive Not RecruitingNCT07217158
What this trial is testing

Role of ROS and cAMP-PKA Biomarkers in ADPKD

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Mayo Clinic 100
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation